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Background and Objectives More insight into donor health and behaviour may
contribute to more efficient and focused strategies regarding donor care and
management. Donor InSight (DIS) is a Dutch cohort study of blood and plasma
donors. We aimed to outline the objectives and methods of DIS, describe the
cohort, and compare it to the active Dutch donor population.
Materials and Methods In 2007-2009 (DIS-I, n = 31 338) and 2012-2013 (DIS-II,
34 826, of whom 22 132 also participated in DIS-I) questionnaire data on demo-
graphics, donation, lifestyle, family composition, health and disease were col-
lected. A second follow-up (DIS-III, n = 3046), including donors with differing
haemoglobin trajectories, was completed in 2015-2016. DIS-III includes data on
genetic determinants, iron and red cell indices. Representativeness of the DIS-I
sample for the entire Dutch donor population was assessed by comparing charac-
teristics of both.
Results Donor InSight was initially set up because of a need for more detailed
information and evidence as a basis for decision-making in blood banks. DIS-I
sample is comparable to the total Dutch donor population in terms of age, body
mass index, haemoglobin level, blood pressure, blood type and donation
behaviour.
Conclusion Donor InSight is a cohort study representative of the Dutch donor
population. It provides evidence to support evidence-based decision making.
Key words: blood donors, demographics, donor health, epidemiology, lifestyle.
Introduction
Blood donor research is an expanding field in which
experts in epidemiology, medicine, psychology and soci-
ology collaborate to safeguard a sufficient and safe blood
supply [1–4]. Despite recent decreases in the use of blood
products, forecasts of increasing blood demands with
concomitantly decreasing numbers of donors due to an
ageing population stress the need to investigate donor
behaviour and health [5]. Greater insight into donor
health and donor behaviour could contribute to a more
efficient and focused strategy regarding donor care and
management and further ensure sufficient blood supply.
It is crucial that a donor pool is stable, healthy, diverse
and large enough to ensure availability of all needed
blood products. All blood donors are screened prior to
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each donation, in order to estimate whether a donor (1)
can cope with the blood (components) loss associated
with donation and (2) can donate blood of adequate qual-
ity [6, 7]. Two understudied aspects of blood donation are
its health effects and donor behaviour. With every dona-
tion, fluids and substances like iron, proteins and blood
cells are lost and these need to be replaced to maintain
homeostasis. A recent study has shown that these replace-
ments can take more time than the widely accepted mini-
mum donation interval of 56 days for whole blood
donations [8]. Although blood donation is generally con-
sidered to be safe, observations of vasovagal reactions,
needle reactions, and fatigue have been reported [9, 10].
Knowledge of health effects and recovery from donation
is needed to make sure that donors can safely continue to
donate.
The cohort study ‘Donor InSight’ (DIS) was set up to
gain insight into the characteristics and motivation of
blood and plasma donors in the Netherlands, and into the
health effects of blood donation [11]. Knowledge of both
health and behavioural effects of donation contributes to
keeping donors healthy and reducing the number of
deferred and lapsed donors. The aim of this study is to
outline the objectives and methods of DIS, describe the
cohort, and compare it to the active Dutch donor
population.
Materials and methods
Dutch donor population
In 2009, the Dutch donor population consisted of 404 184
registered voluntary non-remunerated donors aged
18–70 years. Sanquin is the only organisation in the
Netherlands authorised to collect and supply blood prod-
ucts. New donors are registered in the blood bank infor-
mation system (ePROGESA, MAK-SYSTEM International
Group, Paris, France), after which donors are invited for
an initial eligibility test and blood is drawn for screening
and blood typing purposes. Donors must meet several cri-
teria to be eligible to donate [12]. Certain health condi-
tions and high-risk behaviours can lead to temporary or
permanent deferral from donation. From their registration
in the system, all donors are continuously registered as
‘active’, except when they are deferred or deregistered.
Deregistration either takes place upon the donor’s request,
or after repeated unsuccessful attempts to contact a
donor.
Donor InSight
Donor InSight was initially set up because of a need for
more detailed information and evidence as a basis for
decision-making in blood banks. The first round of DIS,
DIS-I, was initiated to set up a representative cohort of
the Dutch donor population regarding donor characteris-
tics, donor motivations and health effects of blood dona-
tion. At the second round, DIS-II, the cohort was turned
into a dynamic cohort to ensure that new donors would
also be represented, by complementing the DIS-I sample
with new randomly selected donors. The most recent
round, DIS-III, aimed specifically to investigate associa-
tions of lifestyle behaviours and genetic factors with
blood parameters, thereby making use of the data col-
lected in DIS-I and -II.
Donor InSight-I
Objectives of DIS-I were to (1) study donor characteristics
and differences between new and regular donors; whole
blood and plasma donors; and regional differences, (2)
identify motivations and barriers of donation among new
and current donors and non-return reasons, and in addi-
tion whether these are related to donor characteristics, (3)
determine main reasons of temporary and permanent
donor deferral and its relation to future donor show beha-
viour, (4) investigate the effects of different strategies to
increase donor show behaviour and (5) study features of
the healthy donor effect.
Between April 2007 and April 2009 50 000 ‘active’
donors were invited to participate in DIS-I (Fig. 1). Each
month except for July and December a random sample of
approximately 2000 ‘active’ donors was selected. An invi-
tation letter with an information brochure, a reply card
and a paper-and-pencil questionnaire were sent by mail.
After 3 weeks, all non-responders (n = 22 334) received a
reminder. Of all 50 000 donors 5210 (10%) replied that
they could not or would not participate, mainly because
they were not interested, faced time constraints or had
concerns based on principles. No response was obtained
from 13 452 (27%) donors. Non-responders were more
often male (52% vs. 47%) and had donated less often
(median number of donations 19 vs. 24). In total, 31 338
(63%) participants returned completed questionnaires.
Donor InSight-II
For DIS-II objectives from DIS-I were extended with the
aims to (1) investigate strategies to increase and factors
that influence donor retention, (2) study health effects of
donations and (3) study lifestyle and donor show
behaviours.
Between 2012 and 2013 all still eligible 29 532 DIS-I
participants were invited for DIS-II. DIS-I donors were
considered eligible if they gave consent for participation
in future studies, had donated at least once since
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22 132 (75%) DIS-II participants 
DIS-III: 2868 (47%) provided blood samples and/or questionnaire information  
              2552 (42%) provided blood samples and at least the general questionnaire  
Questionnaires 
DNA sequencing 
Blood sampling 
50 000 randomly selected donors invited (~13% of 
the total Dutch donor population) 
- 5210 refused participation  
- 13 452 no response 
- 1098 gave no consent to be re -
contacted 
- 708 excluded (deceased, 
emigrated or unknown address) 
20 468 randomly selected 
donors invited  
DONOR INSIGHT 
DIS-I: 31 338 (63%) participated in total 
Questionnaires 
 
- 1763 refused participation  
- 6011 no response  
OPTIONAL: 
- Linkage to 
donor 
database 
- Linkage to 
Statistics 
Netherlands 
- Linkage to 
medical and 
disease 
registries 
12 694 (62%) newly invited participants 
29 532 DIS-I participants invited  
- 1468 refused participation  
- 5932 no response  
DIS-II: 34 826 (70%) participated in total 
Questionnaires 
- 1662 gave no consent to be re -
contacted 
- 119 excluded (deceased, 
emigrated or special type of donor) 
6140 DIS -I and/or DIS-II 
participants invited  
- 2548 with declining Hb levels  
- 2071 with stable Hb levels  
- 1521 randomly selected donors  
 - 2324 refused participation  
- 770 no response 
3046 (50%) provided blood 
samples and/or questionnaire 
information 
- 178 incomplete informed consent 
- 86 could not be reached 
- 8 not eligible 
- 10 not interested anymore 
DIS-III accelerometer study: 741 provided objectively measured physical activity and 
sedentary behaviour data 
1944 DIS -III participants invited  
1269 (65%) interested  
904 contacted by phone or e-mail  
800 received an accelerometer 
- 59 did not provide complete data /    
- informed consent 
TIME 
Fig. 1 Donor InSight flowchart.
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registration as donor, were not deceased and had not
moved to an untraceable address. Of the DIS-I donors
invited, 22 132 (75%) participated in DIS-II. A new ran-
dom sample of 20 468 active donors was also invited for
DIS-II, of whom 12 694 (62%) participated. Reminders
were sent to all initial non-responders (n = 21 178). Of
all 50 000 donors invited for DIS-II, 3231 donors replied
that they could not or would not participate. In total,
34 826 (70%) participants completed the DIS-II question-
naire (Fig. 1).
Donor InSight-III
The objectives of DIS-III were to (1) investigate genetic
and lifestyle behaviour determinants in relation to declin-
ing vs. stable Hb levels and donation-related iron defi-
ciency, (2) assess whether identified genetic factors can
improve the performance of previously developed predic-
tion models, (3) study genetic determinants of iron meta-
bolism in relation to their iron status and red blood cell
indices and (4) investigate associations of Hb trajectories
and iron deficiency with several health symptoms in
whole blood donors.
Between April 2015 and December 2016 6140 DIS-I
and/or DIS-II participants were invited to participate in
DIS-III. DIS participants of whom the Hb level of their
first donor screening was known were considered eligible.
Three groups of DIS participants were invited. A group of
donors with stable (n = 2071) and a group with declining
(n = 2548) Hb levels were distinguished by fitting growth
mixture models on Hb measurements [13]. These models
were fitted on whole blood donors who registered
between January 1, 2005 and December 31, 2012 and
had at least one visit after the first donation. A third
group was randomly selected (n = 1521) from DIS-I and/
or DIS-II participants. An invitation letter with informa-
tion brochure including a link to online questionnaires,
and a pictorial blood loss assessment chart (PBAC) for
women only [14] were sent by mail. After 2 weeks, all
non-responders (n = 4530) received a reminder. Starting
from 2 weeks after the reminder, remaining non-respon-
ders (n = 3652) were contacted by phone with a maxi-
mum of three attempts. Non-responders of whom e-mail
addresses were known also received a reminder by e-mail
(n = 1331). Of all 6140 donors invited for DIS-III, 2324
donors replied that they could or would not participate,
mainly because of health reasons and time constraints. A
total of 770 donors could not be reached. In total 3046
(50%) participants provided blood samples and/or ques-
tionnaire information for DIS-III of whom 2868 (47%)
participants provided informed consent. In total 2552 par-
ticipants provided blood samples and completed at least
the general questionnaire (Fig. 1).
Of all DIS-participants, a vast majority (27 450 (88%)
of DIS-I and 28 790 (83%) of DIS-II participants) gave
informed consent for linkage to the blood bank informa-
tion system, external databases and public registries such
as cancer registries. DIS was approved by the Medical
Ethical Committee Arnhem-Nijmegen in the Netherlands
and for DIS-III by the Medical Ethical Committee of the
Academic Medical Center, Amsterdam, the Netherlands.
All participants gave their written, informed consent.
Measurements
An overview of all data collected during DIS-I, -II and
-III is provided in Table 1. The questionnaire for DIS-I
was self-administered, mainly multiple choice, covered
six topics in Dutch. During DIS-II, the same, slightly
updated questionnaire was used. These questionnaires
were, with exception of the questions about donation,
adapted from the Nijmegen Biomedical Study question-
naire [15]. In addition, several psychological constructs
were inquired with regard to donation behaviour. This
included constructs of the Theory of Planned Behaviour
and were based on previously published measures and
concepts such as trust and altruism [16–18].
Donor InSight-III participants were requested to com-
plete questionnaires on symptoms associated with iron
deficiency; general health (SF12); [19] the international
physical activity questionnaire (IPAQ); [20] a shortened
version of a food frequency questionnaire (FFQ) [21],
designed to estimate iron intake; and questions on alco-
hol use, smoking and medication, adapted from the DIS-I
and -II questionnaires. Furthermore, female participants
were again asked to fill out questions about their men-
struation patterns, pregnancies and contraceptive use. In
DIS-III the PBAC was used to quantify menstrual blood
loss [14].
Blood sampling, genotyping and accelerometers
(DIS-III)
Blood for DIS-III was sampled at all blood bank collection
sites throughout the Netherlands. Four blood samples
(12 ml in total) were taken from the sampling pouch dur-
ing a routine blood donation if donors were eligible. If a
donor was deferred from donation or not willing to make
a full donation (n = 836, 29% of all blood samples),
blood was sampled through venepuncture. Blood samples
were sent to Amsterdam and processed within 24 h after
donation. Blood samples for zinc protoporphyrin (ZPP;
Model 206D, Aviv Biomedical, Lakewood, NJ) were stored
in EDTA whole blood at 4–6°C and measured within
10 days after sampling. Full blood counts (XT-2000, Sys-
mex, Kobe, Japan) were performed immediately after
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processing, after which this EDTA whole blood sample
was used to determine free haemoglobin (EON plate
reader, Biotek, NH, USA) and to determine haemolysis
levels 28 days after blood sampling. Ferritin was mea-
sured using plasma from lithium heparin tubes (Architect
Ci8200, Abbott Laboratories, IL, USA) and were stored at
-80°C. Total cholesterol, high density lipoprotein choles-
terol and triglycerides were also measured from lithium
heparin tubes (Cobas C systems, Roche/Hitachi, Man-
nheim, Germany). Both ferritin and blood lipid levels
were measured within 12 months after blood sampling.
DNA was extracted from EDTA whole blood samples
stored at -30°C. A part of the entire genome was anal-
ysed, including high-throughput genotyping using the UK
Biobank Axiom Array (Thermo Fisher, Waltham, MA,
USA) that contains 820 967 single nucleotide polymor-
phisms (SNP) and insertion/deletion (INDEL) markers
[1, 22].
A subset of DIS-III participants were invited through
the DIS-III questionnaire to additionally participate in an
accelerometer study to objectively assess physical activity
and sedentary behaviour (wGT3X-BT and GT3X Acti-
graph, Pensacola, FL, USA). Accelerometers provide infor-
mation on activity as counts per minute (cpm). Activity
was categorized as sedentary ≤99; light-intensity 100–
2019; moderate-intensity 2020–5998; and vigorous-inten-
sity ≥5999 cpm. according to the well-established Troiano
(2008) cut-off points [23].
Data used to assess characteristics and
representativeness of DIS
For the current analyses, data on demographics, lifestyle,
health and disease, and donor and donation information
were used. Level of education was defined as the highest
level of education completed, being primary education,
prevocational secondary education and lower general sec-
ondary education (categorized as low education), senior
secondary vocational training, senior general secondary
education and pre-university education (categorized as
medium education), or higher professional education and
university (categorized as high education). Household
composition was measured as living alone, living alone
with children (categorized as living alone (with children)),
living with spouse or partner, living with spouse or part-
ner and children (categorized as living with partner (and
children)), living with parents/family/friends, living as a
student in a dorm/with roommates and other (categorized
as other). Employment was measured using the question
“To which group do you belong?” with the options (mul-
tiple answers possible): employed, retired, off work due to
illness, unemployed/searching for a job, disabled, house-
wife/-man, student with a job, student without a job and
other (categorized as other). Part-time and full-time
employment were categorized by using the question “If
you have paid work, how many hours do you work dur-
ing an average week?”. Using information from these two
questions, employment was categorized as full-time
(≥36 h/week), part-time, student/unemployed and retired.
Employment, household composition and education were
measured once, these questions were asked only in DIS-II
in case the donor did not participate in DIS-I.
Physical activity regarded medium to high intensity
workouts for DIS-I and -II; participants were asked to for
instance include mountain biking, but exclude cycling to
work or playing chess. The IPAQ-short form was used in
DIS-III [24] to estimate time spent in moderate to vigor-
ous physical activity (MVPA) and sedentary behaviour. In
a subset of the DIS-III sample sedentary behaviour and
physical activity were also objectively measured using
accelerometers. MVPA and sedentary behaviour are
reported as mean minutes per day.
Smoking was measured as current smoker, former smo-
ker and, never smoked. Alcohol consumption was mea-
sured as less than once a week, 1–2 days/week, 3–5 days/
week and (almost) every day. The presence of medical
conditions was assessed in DIS-I and DIS-II by asking
whether these conditions had ever been diagnosed by a
physician. In DIS-III name of (prescribed) medication or
vitamin, preparations and reason for prescription was
requested. Answers were categorized according to the
World Health Organization recommended Anatomical
Therapeutic Chemical classification system [25]. To enable
comparison in terms of donor (demographic) and dona-
tion information of the DIS-I sample to the total donor
population, data on all active and non-active donors on
the 31st of December 2009, corresponding with the tim-
ing of DIS-I, were extracted including all whole blood
and plasma donations made in 2007-2009. Age at 31-12-
2009 (years), height (m), weight (kg), body mass index
(BMI, kg/m2), mean Hb (mmol/l, mean of measurements
in 2007–2009), mean systolic and diastolic blood pres-
sures (SBP and DBP, mm Hg, mean of all measurements
in 2007–2009), mean donation interval (mean of all inter-
vals between donations in 2007–2009) and total number
of donations in 2007–2009 were obtained or calculated
from this database.
Statistics
Descriptive results of the DIS-I, -II and -III population in
terms of demographic characteristics, donation, lifestyle
behaviours and health and disease are reported as num-
bers and proportions for binary data, or mean values –
standard deviations or medians with interquartile ranges
in case of normally distributed or skewed continuous data
© 2018 The Authors.
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respectively. Mean values – standard deviations for age,
height, weight, BMI, Hb, SBP and DBP, median donation
intervals (with interquartile ranges) and proportions of
donors with 0, 1–3, 4–6, 7–9 or 10 or more donations, of
participants with blood type A, B, AB or O, and of whole
blood donors are presented.
Results
Representativeness DIS-I
In Table 2, characteristics of both the DIS population and
the total active donor population on December 31st 2009
are summarised. This table shows that the DIS population
is very similar to the total active donor population. Only
the number of donations differed, DIS donors were more
likely to have made a larger number of donations in
2007–2009 as compared with all donors.
Characteristics of DIS-I, -II and -III
Characteristics of the DIS-I, -II and -III populations are
shown in Tables 3, 4 and 5 respectively. Approximately
one-third of the donors participating in DIS-I and -II
completed higher professional education or university
(34–37% and 36–39% in DIS-I and -II respectively),
which is more than in the general Dutch population (32%
of the Dutch 25–64 year old) [26].
Donor InSight donors were mainly living with a partner
(and children), DIS-I: 74–86% and DIS-II: 77–84%, and
often full-time employed (DIS-I: 19–68% and DIS-II: 35–
37%). The percentage of smokers ranged from 8 to 17%
(DIS-I – DIS-III), which is lower compared with the general
Dutch population (23% among adults in 2016) [27] and
consumption of alcohol 1–2 days per week ranged from 24
to 33. The prevalence of hypertension, high cholesterol and
diabetes was relatively low in comparison with the general
Dutch population: ranging from 1% (women with diabetes)
to 16% (men with hypertension) in DIS-I and from 1% (dia-
betes) to 15% (hypertension) in DIS-II [11].
Discussion
Donor InSight is a unique cohort study on randomly
selected donors from the Dutch donor population and com-
prises data regarding epidemiological and psychosocial
Table 2 Characteristics of the Donor InSight I sample and the total active donor population, based on data from the donor database as of on 31-12-
2009
DIS-I sample Active donor population
Men
(n = 14 782)
Women
(n = 16 556)
Men
(n = 182 751)
Women
(n = 211 794)
Age (years) 51 – 12 44 – 13 48 – 13 42 – 15
Height (cm) 182 – 7 169 – 6 182 – 7 170 – 6
Weight (kg) 84 – 14 70 – 13 83 – 14 70 – 13
BMI (kg/m2) 26 – 3 25 – 4 26 – 3 25 – 4
Haemoglobin (mmol/l) 94 – 06 85 – 06 93 – 12 82 – 15
SBP (mm Hg) 134 – 13 126 – 14 134 – 13 125 – 14
DBP (mm Hg) 81 – 8 78 – 8 81 – 8 77 – 8
Donation interval (days) 105 (80–161) 152 (124–209) 107 (79–168) 147 (113–208)
Donations in 2007–2009 (%)
0 507 (3) 978 (6) 8599 (5) 22 254 (11)
1–3 2060 (14) 4213 (26) 43 167 (24) 76 325 (36)
4–6 3140 (21) 5501 (33) 39 260 (22) 59 975 (28)
7–9 2933 (20) 4126 (25) 31 512 (17) 38 110 (18)
10 6133 (42) 1726 (10) 60 213 (33) 15 130 (7)
Blood type, %
A-/A+ 8/33 8/32 7/32 7/30
B-/B+ 2/8 2/8 2/8 2/7
AB-/AB+ 1/3 1/3 1/3 1/3
0-/0+ 10/36 11/35 9/36 10/34
Whole blood donors (%) 11 565 (78) 13 826 (84) 143 652 (79) 165 456 (78)
DBP, diastolic blood pressure; SBP, systolic blood pressure.
Continuous data are shown as mean – standard deviation, donation interval as median (interquartile range), numbers of donors n (%) are shown for
categories.
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aspects of blood donation. As shown in this study, DIS-I
donors are representative of the Dutch donor population.
Differences in age, number of donations and the larger
number of donations in 2007–2009 between the DIS-sam-
ple and the Dutch donor population is probably due to
the fact that donors who participated in DIS were ran-
domly selected from the active donor population at dif-
ferent time points in the period 2007–2009. In equal
circumstances, a random selection of the active donor
population in April 2007 will obviously be older in
December 2009 than the active donor population at that
point. Furthermore, donors who stopped donating will be
present in the DIS population, but not in the active total
donor population in December 2009. Vice versa, the total
donor population includes recently registered donors who
could not have been part of DIS. Indeed, the total donor
population includes 26% newly registered donors, while
only 01% of the DIS donors were newly registered.
Multiple other large studies among blood donors have
also collected questionnaire and biological data, though
with different study aims and study populations. The
INTERVAL study, for example, is a randomized controlled
trial assigning donors to different donation intervals [1].
The Danish Blood Donor study invited all donors visiting
the blood bank who had donated at least once [4]. Last,
the Donor Iron Status Evaluation (RISE) study investi-
gated four groups of donors (male and female, frequent
and first-time/reactivated) [28]. So a unique aspect of DIS
is that the inclusion into DIS was not directly linked to
actual donations, thereby enhancing the participation of
potentially less motivated donors and donors with blood
types that are less frequently requested [2–4].
Table 3 Demographic and lifestyle characteristics of the Donor InSight I sample
DIS-I sample
Men
(n = 14 782)
Women
(n = 16 556)
Whole blood donors
(n = 11 565)
Othera
(n = 3217)
Whole blood donors
(n = 13 826)
Othera
(n = 2730)
Demographic characteristics
Education
Medium 3905 (34) 1072 (34) 5102 (37) 939 (35)
High 4232 (37) 1149 (36) 4675 (34) 921 (34)
Household
Living alone (with children) 1246 (11) 349 (11) 2574 (19) 592 (22)
Living with partner (and children) 9820 (85) 2770 (86) 10 309 (75) 2008 (74)
Other 499 (4) 89 (3) 943 (7) 118 (4)
Employmentb
Full-time 7935 (68) 2134 (66) 2768 (19) 552 (20)
Part-time 1528 (13) 415 (13) 8067 (58) 1557 (56)
Retired 1582 (14) 513 (16) 589 (4) 160 (6)
Other 583 (5) 161 (5) 2554 (18) 509 (18)
Lifestyle and health status
Current smoker 1935 (17) 450 (14) 2244 (16) 403 (15)
Alcohol consumption
<once/week 2281 (20) 661 (21) 4993 (36) 888 (33)
1–2 days a week 3543 (31) 936 (29) 3374 (24) 663 (24)
3–5 days a week 2757 (24) 707 (22) 1931 (14) 418 (15)
(Almost) every day 2265 (20) 692 (22) 1475 (11) 311 (12)
Physical activity (hours sports/week) 25 (15 – 40) 30 (20 – 45) 20 (13 – 30) 20 (15 – 35)
Hypertensionc 1880 (16) 504 (16) 1751 (13) 413 (15)
High cholesterolc 1176 (10) 309 (10) 664 (5) 157 (6)
Diabetes mellitusc 193 (2) 63 (2) 141 (1) 38 (1)
Binary data are shown as numbers (%), continuous data are shown as mean – standard deviation, or as median (interquartile range) in case of skewed
data.
aThe category ‘other donors’ mainly contains plasmapheresis donors.
bDue to the possibility of multiple answers per donor, the sum of the number of donors per categories may exceed the total number of donors.
cAs diagnosed by a physician.
© 2018 The Authors.
Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion.
Vox Sanguinis (2019) 114, 117–128
124 T. C. Timmer et al.
Strengths of DIS include the large study population
and high representativeness of the Dutch donor popula-
tion. This makes the study particularly useful for dona-
tion-related research questions for which the donor
database is lacking information. Due to its prospective
design and multiple measurements DIS also provides a
unique opportunity to study questions in fields like public
health, social sciences, epidemiology, (bio)statistics,
genetics and haematology. The DIS cohort is a relatively
healthy cohort that can serve as control sample [29].
Another strength is the objectively measured physical
activity and sedentary behaviour in a subset of the DIS-
III sample. Benefits of the study set-up are that (1) many
repeated measurements with different intervals are avail-
able from the donor database and (2) additional data can
be obtained relatively easily because (still donating) par-
ticipants return to donation centres and are generally
very willing to participate in research which is reflected
in the DIS response rates ranging from 42 to 70%. Other
strengths include the possibility of linking study results
to the donor database and to morbidity and mortality
data. A potential weakness is the selective study popula-
tion because of (1) the voluntary nature of donation, (2)
donor screening procedures and (3) non-response to study
invitations [11]. As with all studies, but particularly in
the present circumstances, one should keep in mind that
extrapolation of conclusions to the general population
should be done with great caution.
Donor InSight data provide many more research oppor-
tunities because of the longitudinal questionnaire infor-
mation, but also the biomedical and genetic data.
Information on genetic markers can be used for research
purposes, such as to study associations between Alzhei-
mer’s disease and blood donation, between iron indices
and autoimmune/inflammatory disorders or between
blood donation and cancer common variants.
Donor InSight is a cohort study of a representative
sample of the Dutch donor population. The cohort can
Table 4 Demographic and lifestyle characteristics of the Donor InSight II sample
DIS-II sample
DIS-I participants
(n = 22,132)
Newly recruiteda
(n = 12,694)
Total
(n = 34,826)
Demographic characteristics
Educationb
Medium 7679 (35) 4721 (37) 12 400 (36)
High 7959 (36) 4967 (39) 12 926 (37)
Household
Living alone (with children) 3161 (14) 1873 (15) 5034 (14)
Living with partner (and children) 18 529 (84) 9766 (77) 28 295 (81)
Other 405 (2) 1037 (8) 1442 (4)
Employment
Full-time 8322 (35) 5029 (37) 13 351 (36)
Part-time 7741 (33) 4496 (33) 12 237 (33)
Retired 3844 (16) 1307 (10) 5151 (14)
Other 3806 (16) 2698 (20) 6504 (17)
Lifestyle and health status
Current smoker 2658 (12) 1704 (13) 4362 (13)
Alcohol consumption
<once/week 5685 (29) 3504 (31) 9189 (30)
1–2 days a week 5934 (30) 3709 (33) 9643 (31)
3–5 days a week 4473 (23) 2405 (21) 6878 (22)
(Almost) every day 3481 (18) 1630 (14) 5111 (17)
Physical activity (hours sports/week) 2 (1–4) 2 (2–4) 2 (1–4)
Hypertensionc 3092 (15) 1227 (10) 4319 (13)
High cholesterolc 1628 (8) 540 (4) 2168 (7)
Diabetes mellitusc 449 (2) 153 (1) 602 (2)
Binary data are shown as numbers (%), continuous data are shown as mean – standard deviation, or as median (interquartile range) in case of skewed
data.
aThese donors did not participate in DIS-I and were newly recruited for DIS-II.
bDue to the possibility of multiple answers per donor, the sum of the number of donors per categories may exceed the total number of donors.
cAs diagnosed by a physician.
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been used to study donor characteristics, motivations and
barriers of donation, donor deferral in relation to future
donor show behaviour and the healthy donor effect. Cur-
rently the DIS cohort is used to study lifestyle behaviours
and genetic determinants of Hb trajectories. The DIS data
may provide answers to many research questions that
cannot at all be analysed by our research team.
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